![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/08/2909738/0/en/RS-BioTherapeutics-Announces-Research-Collaboration-with-University-of-Colorado-School-of-Medicine.html
https://www.globenewswire.com/news-release/2024/04/30/2872441/0/en/RS-BioTherapeutics-Launches-Crowdfunding-Campaign-Through-StartEngine.html
https://www.globenewswire.com/news-release/2024/04/25/2869782/0/en/RS-BioTherapeutics-Adds-Jane-Wright-Mitchell-Pharm-D-J-D-to-Business-Advisory-Board.html
https://www.globenewswire.com/news-release/2024/03/18/2847984/0/en/RS-BioTherapeutics-Selected-for-Presentation-at-American-Thoracic-Society-s-2024-Respiratory-Innovation-Summit.html
https://www.globenewswire.com/news-release/2024/03/18/2847984/0/en/RS-BioTherapeutics-Selected-for-Presentation-at-American-Thoracic-Society-s-2024-Respiratory-Innovation-Summit.html
https://www.globenewswire.com//news-release/2024/02/21/2832870/0/en/RS-BioTherapeutics-Creates-Therapeutic-Expert-Council-to-Provide-Guidance-on-Development-of-First-in-Class-Agent-Focused-on-Chronic-Obstructive-Pulmonary-Disease-and-Idiopathic-Pul.html
https://www.globenewswire.com//news-release/2023/10/31/2770418/0/en/RS-BioTherapeutics-Promotes-Michelle-L-Shuffett-MD-to-Chief-Medical-Officer.html
https://www.globenewswire.com//news-release/2023/08/29/2733689/0/en/RS-BioTherapeutics-and-National-Institutes-of-Health-Execute-Research-Collaboration-Agreement-to-Evaluate-Prevention-and-Treatment-of-Idiopathic-Pulmonary-Fibrosis.html
https://www.globenewswire.com/news-release/2023/06/05/2681817/0/en/RS-BioTherapeutics-Appoints-Michelle-L-Shuffett-MD-as-SVP-of-Medical-and-Scientific-Affairs.html
https://www.globenewswire.com/news-release/2023/05/15/2668994/0/en/RS-BioTherapeutics-Joins-BioNTX-Bioscience-and-Healthcare-Innovation-Trade-Organization.html